Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/development-of-novel-frog-skin-peptide-scaffolds-with-selectivity-nBTIG4eCAK
References (69)
-
S. Gunasekera, Fiona Foley, R. Clark, L. Sando, L. Fabri, D. Craik, N. Daly (2008)
Engineering stabilized vascular endothelial growth factor-A antagonists: synthesis, structural characterization, and bioactivity of grafted analogues of cyclotides.Journal of medicinal chemistry, 51 24
-
S. Luckett, R.Santiago Garcia, J. Barker, Al.V Konarev, P.R Shewry, A. Clarke, R.L Brady (1999)
High-resolution structure of a potent, cyclic proteinase inhibitor from sunflower seeds.Journal of molecular biology, 290 2
-
V. Hruby, Minying Cai, James Cain, Joel Nyberg, D. Trivedi (2011)
Design of novel melanocortin receptor ligands: multiple receptors, complex pharmacology, the challenge.European journal of pharmacology, 660 1
-
L. Chan, D. Craik, N. Daly (2016)
Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapyScientific Reports, 6
-
V. Hruby, Minying Cai, Joel Nyberg, Dhanasekaran Muthu (2011)
Approaches to the rational design of selective melanocortin receptor antagonistsExpert Opinion on Drug Discovery, 6
-
Minying Cai, A. Mayorov, Jinfa Ying, M. Staňková, D. Trivedi, Christopher Cabello, V. Hruby (2005)
Design of novel melanotropin agonists and antagonists with high potency and selectivity for human melanocortin receptorsPeptides, 26
-
D. Macneil, A. Howard, X. Guan, T. Fong, R. Nargund, M. Bednarek, M. Goulet, D. Weinberg, A. Strack, D. Marsh, Howard Chen, Chun-Pyn Shen, Airu Chen, C. Rosenblum, T. Macneil, M. Tota, E. MacIntyre, L. Ploeg (2002)
The role of melanocortins in body weight regulation: opportunities for the treatment of obesity.European journal of pharmacology, 440 2-3
-
W. Vranken, W. Boucher, T. Stevens, R. Fogh, A. Pajon, M. Llinás, E. Ulrich, J. Markley, J. Ionides, E. Laue (2005)
The CCPN data model for NMR spectroscopy: Development of a software pipelineProteins: Structure, 59
-
T. Sawyer, P. Sanfilippo, V. Hruby, Michael Engel, C. Heward, J. Burnett, M. Hadley (1980)
4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity.Proceedings of the National Academy of Sciences of the United States of America, 77 10
-
M. Hadley, R. Dorr (2006)
Melanocortin peptide therapeutics: Historical milestones, clinical studies and commercializationPeptides, 27
-
A. Wilczynski, K. Wilson, J. Scott, A. Edison, C. Haskell-Luevano (2005)
Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template.Journal of medicinal chemistry, 48 8
-
I. Zimanyi, M. Pelleymounter (2003)
The role of melanocortin peptides and receptors in regulation of energy balance.Current pharmaceutical design, 9 8
-
R. Clark, H. Fischer, L. Dempster, N. Daly, K. Rosengren, S. Nevin, F. Meunier, D. Adams, D. Craik (2005)
Engineering stable peptide toxins by means of backbone cyclization: stabilization of the alpha-conotoxin MII.Proceedings of the National Academy of Sciences of the United States of America, 102 39
-
Ben Webb, A. Sali (2016)
Comparative Protein Structure Modeling Using MODELLERCurrent Protocols in Protein Science, 86
-
D. Palmer, Juliana Gonçalves, Louise Hansen, Boqian Wu, Helle Hald, Sanne Schoffelen, F. Diness, Sebastian Quement, T. Nielsen, M. Meldal (2017)
Click-Chemistry-Mediated Synthesis of Selective Melanocortin Receptor 4 Agonists.Journal of medicinal chemistry, 60 21
-
Jing Yu, L. Gimenez, C. Hernandez, Yiran Wu, A. Wein, G. Han, K. McClary, S. Mittal, K. Burdsall, B. Stauch, Lijie Wu, S. Stevens, A. Peisley, Savannah Williams, Valerie Chen, G. Millhauser, Suwen Zhao, R. Cone, R. Stevens (2020)
Determination of the melanocortin-4 receptor structure identifies Ca2+ as a cofactor for ligand bindingScience, 368
-
A. Ducrest, L. Keller, A. Roulin (2008)
Pleiotropy in the melanocortin system, coloration and behavioural syndromes.Trends in ecology & evolution, 23 9
-
F. Al-Obeidi, A. Castrucci, A. Castrucci, M. Hadley, V. Hruby (1989)
Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics.Journal of medicinal chemistry, 32 12
-
L. Chan, Veronica Zhang, Yen‐Hua Huang, N. Waters, P. Bansal, D. Craik, N. Daly (2013)
Cyclization of the Antimicrobial Peptide Gomesin with Native Chemical Ligation: Influences on Stability and BioactivityChemBioChem, 14
-
M. Bednarek, T. Macneil, R. Kalyani, R. Tang, L. Ploeg, D. Weinberg (2001)
Selective, high affinity peptide antagonists of alpha-melanotropin action at human melanocortin receptor 4: their synthesis and biological evaluation in vitro.Journal of medicinal chemistry, 44 22
-
R. Adan, T. Vink (2001)
Drug target discovery by pharmacogenetics: mutations in the melanocortin system and eating disordersEuropean Neuropsychopharmacology, 11
-
L. Ploeg, W. Martin, A. Howard, R. Nargund, C. Austin, X. Guan, J. Drisko, D. Cashen, I. Sebhat, A. Patchett, D. Figueroa, A. Dilella, Brett Connolly, D. Weinberg, Carina Tan, O. Palyha, S. Pong, T. Macneil, C. Rosenblum, Aurawan Vongs, R. Tang, Hong Yu, A. Sailer, T. Fong, C. Huang, M. Tota, R. Chang, R. Stearns, C. Tamvakopoulos, G. Christ, D. Drazen, B. Spar, R. Nelson, D. Macintyre (2002)
A role for the melanocortin 4 receptor in sexual functionProceedings of the National Academy of Sciences of the United States of America, 99
-
H. Schiöth, F. Mutulis, R. Muceniece, P. Prusis, J. Wikberg (1998)
Discovery of novel melanocortin4 receptor selective MSH analoguesBritish Journal of Pharmacology, 124
-
M. Hadley, V. Hruby, Jiwen Jiang, SHUBH Sharma, Jody Fink, C. Haskell-Luevano, D. Bentley, F. Al-Obeidi, T. Sawyer (1996)
Melanocortin receptors: identification and characterization by melanotropic peptide agonists and antagonists.Pigment cell research, 9 5
-
R. Eliasen, N. Daly, B. Wulff, T. Andresen, K. Conde-Frieboes, D. Craik (2012)
Design, Synthesis, Structural and Functional Characterization of Novel Melanocortin Agonists Based on the Cyclotide Kalata B1*The Journal of Biological Chemistry, 287
-
Conan Wang, D. Craik (2018)
Designing macrocyclic disulfide-rich peptides for biotechnological applicationsNature Chemical Biology, 14
-
E. Langan, Z. Nie, L. Rhodes (2010)
Melanotropic peptides: more than just ‘Barbie drugs’ and ‘sun‐tan jabs’?British Journal of Dermatology, 163
-
Jianxu Li, Cheng Zhang, Xueqing Xu, Jie Wang, Haining Yu, R. Lai, W. Gong (2007)
Trypsin inhibitory loop is an excellent lead structure to design serine protease inhibitors and antimicrobial peptidesThe FASEB Journal, 21
-
P. Prusis, R. Muceniece, I. Mutule, F. Mutulis, J. Wikberg (2001)
Design of new small cyclic melanocortin receptor-binding peptides using molecular modelling: Role of the His residue in the melanocortin peptide core.European journal of medicinal chemistry, 36 2
-
was supported by an Australian Research Council Future Fellowship (FT1100100226). L. Y. C. was supported by the Advance Queensland Women's Academic Fund -
J. Wikberg (2001)
Melanocortin receptors: new opportunities in drug discoveryExpert Opinion on Therapeutic Patents, 11
-
Clarence Wong, D. Rowlands, C. Wong, T. Lo, G. Nguyen, Hoi-Yeung Li, J. Tam (2012)
Orally active peptidic bradykinin B1 receptor antagonists engineered from a cyclotide scaffold for inflammatory pain treatment.Angewandte Chemie, 51 23
-
W. Fan, B. Boston, R. Kesterson, V. Hruby, R. Cone (1997)
Role of melanocortinergic neurons in feeding and the agouti obesity syndromeNature, 385
-
(2021)
Development of novel frog-skin peptide scaffolds with selectivity towards melanocortin receptor subtypes -
Jinfa Ying, K. Kövér, Xuyuan Gu, G. Han, D. Trivedi, M. Kavarana, V. Hruby (2003)
Solution structures of cyclic melanocortin agonists and antagonists by NMR.Biopolymers, 71 6
-
Stephan Schott-Verdugo, H. Gohlke (2019)
PACKMOL-Memgen: A Simple-To-Use, Generalized Workflow for Membrane-Protein-Lipid-Bilayer System BuildingJournal of chemical information and modeling
-
A. Mayorov, So‐Yeop Han, Minying Cai, Matthew Hammer, D. Trivedi, V. Hruby (2006)
Effects of Macrocycle Size and Rigidity on Melanocortin Receptor‐1 and ‐5 Selectivity in Cyclic Lactam α‐Melanocyte‐Stimulating Hormone AnalogsChemical Biology & Drug Design, 67
-
M. Korsinczky, H. Schirra, K. Rosengren, J. West, Barrie Condie, L. Otvos, M. Anderson, D. Craik (2001)
Solution structures by 1H NMR of the novel cyclic trypsin inhibitor SFTI-1 from sunflower seeds and an acyclic permutant.Journal of molecular biology, 311 3
-
R. Adan, J. Oosterom, R. Toonen, M. Kraan, J. Burbach, W. Gispen (1997)
Molecular pharmacology of neural melanocortin receptors.Receptors & channels, 5 3-4
-
Erica Lovelace, C. Armishaw, M. Colgrave, Maria Wahlstrom, P. Alewood, N. Daly, D. Craik (2006)
Cyclic MrIA: a stable and potent cyclic conotoxin with a novel topological fold that targets the norepinephrine transporter.Journal of medicinal chemistry, 49 22
-
J. Wikberg (1999)
Melanocortin receptors: perspectives for novel drugs.European journal of pharmacology, 375 1-3
-
R. Cone (2000)
The Melanocortin Receptors -
Stephen Getting (2006)
Targeting melanocortin receptors as potential novel therapeutics.Pharmacology & therapeutics, 111 1
-
A. Mayorov, Minying Cai, Erin Palmer, D. Tanaka, James Cain, Matthew Dedek, B. Tan, D. Trivedi, V. Hruby (2011)
Cyclic lactam hybrid α-MSH/Agouti-related protein (AGRP) analogues with nanomolar range binding affinities at the human melanocortin receptors.Bioorganic & medicinal chemistry letters, 21 10
-
U. Malik, O. Silva, I. Fensterseifer, L. Chan, R. Clark, O. Franco, N. Daly, D. Craik (2015)
In Vivo Efficacy of Anuran Trypsin Inhibitory Peptides against Staphylococcal Skin Infection and the Impact of Peptide CyclizationAntimicrobial Agents and Chemotherapy, 59
-
R. Dorr, Ruskin Lines, N. Levine, Christine Brooks, Li Xiang, V. Hruby, M. Hadley (1996)
Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study.Life sciences, 58 20
-
Wenbiao Chen, M. Kelly, Ximena Opitz-Araya, Ruth Thomas, M. Low, R. Cone (1997)
Exocrine Gland Dysfunction in MC5-R-Deficient Mice: Evidence for Coordinated Regulation of Exocrine Gland Function by Melanocortin PeptidesCell, 91
-
R. Clark, Muharrem Akcan, Q. Kaas, N. Daly, D. Craik (2012)
Cyclization of conotoxins to improve their biopharmaceutical properties.Toxicon : official journal of the International Society on Toxinology, 59 4
-
J. Tam, Yi-an Lu, Qitao Yu (1999)
THIA ZIP REACTION FOR SYNTHESIS OF LARGE CYCLIC PEPTIDES : MECHANISMS AND APPLICATIONSJournal of the American Chemical Society, 121
-
Skye Doering, A. Todorovic, C. Haskell-Luevano (2015)
Melanocortin antagonist tetrapeptides with minimal agonist activity at the mouse melanocortin-3 receptor.ACS medicinal chemistry letters, 6 2
-
V. Hruby, Minying Cai, James Cain, A. Mayorov, Matthew Dedek, D. Trivedi (2007)
Design, synthesis and biological evaluation of ligands selective for the melanocortin-3 receptor.Current topics in medicinal chemistry, 7 11
-
T. Durek, Philipp Cromm, A. White, C. Schroeder, Q. Kaas, J. Weidmann, A. Fuaad, O. Cheneval, P. Harvey, N. Daly, Yang Zhou, A. Dellsén, Torben Österlund, N. Larsson, L. Knerr, U. Bauer, H. Kessler, Minying Cai, V. Hruby, A. Plowright, D. Craik (2018)
Development of Novel Melanocortin Receptor Agonists Based on the Cyclic Peptide Framework of Sunflower Trypsin Inhibitor-1.Journal of medicinal chemistry, 61 8
-
Jagdish Sakhiya, Dhruv Sakhiya, Mehul Patel, F. Daruwala (2019)
Case report on premature hair graying treated with Melitane 5% and oral hair supplementsIndian Journal of Pharmacology, 51
-
L. Chan, S. Gunasekera, S. Henriques, N. Worth, Sarah-Jane Le, R. Clark, Julie Campbell, D. Craik, N. Daly (2011)
Engineering pro-angiogenic peptides using stable, disulfide-rich cyclic scaffolds.Blood, 118 25
-
S. Ückert, A. Bannowsky, K. Albrecht, M. Kuczyk (2014)
Melanocortin receptor agonists in the treatment of male and female sexual dysfunctions: results from basic research and clinical studiesExpert Opinion on Investigational Drugs, 23
-
K. Wüthrich (1988)
NMR of proteins and nucleic acids -
Minying Cai, V. Hruby (2016)
The Melanocortin Receptor System: A Target for Multiple Degenerative Diseases.Current protein & peptide science, 17 5
-
Jinfa Ying, Xuyuan Gu, Minying Cai, Matthew Dedek, J. Vagner, D. Trivedi, V. Hruby (2006)
Design, synthesis, and biological evaluation of new cyclic melanotropin peptide analogues selective for the human melanocortin-4 receptor.Journal of medicinal chemistry, 49 23
-
Z. Abdel‐Malek (2001)
Melanocortin receptors: their functions and regulation by physiological agonists and antagonistsCellular and Molecular Life Sciences CMLS, 58
-
M. Bednarek, T. Macneil, R. Tang, T. Fong, M. Cabello, Marta Maroto, A. Teran (2007)
Potent and selective agonists of human melanocortin receptor 5: cyclic analogues of alpha-melanocyte-stimulating hormone.Journal of medicinal chemistry, 50 10
-
V. Hruby (2002)
Designing peptide receptor agonists and antagonistsNature Reviews Drug Discovery, 1
-
Min-Yi Shen, A. Sali (2006)
Statistical potential for assessment and prediction of protein structuresProtein Science, 15
-
I. Farooqi, J. Keogh, G. Yeo, E. Lank, T. Cheetham, S. O’Rahilly (2003)
Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene.The New England journal of medicine, 348 12
-
E. Jackson, M. Heidl, D. Imfeld, Laurent Meeus, R. Schuetz, R. Campiche (2019)
Discovery of a Highly Selective MC1R Agonists Pentapeptide to Be Used as a Skin Pigmentation Enhancer and with Potential Anti-Aging PropertiesInternational Journal of Molecular Sciences, 20
-
V. Hruby, D. Lu, SHUBH Sharma, A. Castrucci, R. Kesterson, F. Al-Obeidi, M. Hadley, R. Cone (1995)
Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors.Journal of medicinal chemistry, 38 18
-
C. Kennedy, J. Huurne, M. Berkhout, N. Gruis, M. Bastiaens, W. Bergman, R. Willemze, J. Bavinck (2001)
Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color.The Journal of investigative dermatology, 117 2
-
Pedro Quimbar, U. Malik, C. Sommerhoff, Q. Kaas, L. Chan, Yen‐Hua Huang, M. Grundhuber, K. Dunse, D. Craik, M. Anderson, N. Daly (2013)
High-affinity Cyclic Peptide Matriptase Inhibitors*The Journal of Biological Chemistry, 288
-
N. Daly, S. Love, P. Alewood, D. Craik (1999)
Chemical synthesis and folding pathways of large cyclic polypeptides: studies of the cystine knot polypeptide kalata B1.Biochemistry, 38 32
-
Ying-kui Yang (2011)
Structure, function and regulation of the melanocortin receptors.European journal of pharmacology, 660 1
- Publisher
- Wiley
- Copyright
- © 2021 Wiley Periodicals LLC.
- eISSN
- 2475-8817
- DOI
- 10.1002/pep2.24209
- Publisher site
- See Article on Publisher Site
Abstract
Melanocortin receptors are pharmaceutically important receptors that are involved in complex physiological functions. They have been associated with various diseases including obesity, erectile dysfunction, acne, and skin cancer. It has been challenging to transform nonselective endogenous agonist and antagonist ligands into selective and potent ligands. In this study, we investigated naturally occurring peptides derived from frog skin secretions for selectivity and activity toward melanocortin receptors. Three peptides (ORB, ORB2K and ranacyclin‐T) were found to have selectivity towards the melanocortin receptor 5 (MC5R). ORB and ORB2K had partial binding affinity at nanomolar concentrations, whereas ranacyclin‐T had 57% binding efficiency at 1.6 μM. Backbone cyclization of ORB and ORB2K altered the binding efficiency to melanocortin receptors. Our results suggest that these frog‐skin peptides could be modified for developing melanocortin‐specific ligands and potentially future therapeutics.
Journal
Peptide Science – Wiley
Published: Jul 1, 2021
Keywords: ; ; ; ;